Every life sciences company knows that patient safety is non negotiable, but the way safety is managed—and the value ...
Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...
Caris projects 2026 total revenue in the range of $1.0 billion to $1.02 billion, anticipating molecular profiling growth of approximately 21% to 22%, and therapy selection volume growth of around 20% ...
Caris Life Sciences Inc. CAI shares are up during Friday’s premarket session following better-than-expected fourth-quarter earnings and a significant interim readout from the company’s Achieve 1 study ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Joel Mokyr, Philippe Aghion and Peter Howitt have been awarded the 2025 Nobel Prize in Economics. (Photo by Jonathan Nackstrand / AFP) / ALTERNATIVE CROP (Photo by JONATHAN NACKSTRAND/AFP via Getty ...
Following a difficult start in 2025, the ever-evolving life sciences segment recovered strongly in the latter half of the year.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results